Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Preferred Shares Issued: 2022-2023

Historic Preferred Shares Issued for Cullinan Therapeutics (CGEM) over the last 1 years, with Mar 2023 value amounting to $1.8 million.

  • Cullinan Therapeutics' Preferred Shares Issued rose 128.12% to $1.8 million in Q1 2023 from the same period last year, while for Mar 2023 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2023, which is 23.16% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Preferred Shares Issued stood at $1.8 million for Q1 2023, which was up 942.86% from $175,000 recorded in Q4 2022.
  • Cullinan Therapeutics' Preferred Shares Issued's 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of $175,000 in Q4 2022.
  • For the 2-year period, Cullinan Therapeutics' Preferred Shares Issued averaged around $1.1 million, with its median value being $1.1 million (2022).
  • Data for Cullinan Therapeutics' Preferred Shares Issued shows a peak YoY spiked of 128.12% (in 2023) over the last 5 years.
  • Over the past 2 years, Cullinan Therapeutics' Preferred Shares Issued (Quarterly) stood at $175,000 in 2022, then surged by 128.12% to $1.8 million in 2023.
  • Its Preferred Shares Issued stands at $1.8 million for Q1 2023, versus $175,000 for Q4 2022 and $1.4 million for Q2 2022.